• Home

  • Documents

  • natcopharma.co.in · M/S. NATCO Pharma Limited NATCO House, Road No.2, Banjara Hills, Hyderabad...
6

natcopharma.co.in · M/S. NATCO Pharma Limited NATCO House, Road No.2, Banjara Hills, Hyderabad 500033, Telangana. Dear Sirs, CERTIFIED For NATCO Pharma Limited M. ADINARAYANA Company

  • Upload
    others

  • View
    36

  • Download
    0

Embed Size (px)

Citation preview

Page 1: natcopharma.co.in · M/S. NATCO Pharma Limited NATCO House, Road No.2, Banjara Hills, Hyderabad 500033, Telangana. Dear Sirs, CERTIFIED For NATCO Pharma Limited M. ADINARAYANA Company
Page 2: natcopharma.co.in · M/S. NATCO Pharma Limited NATCO House, Road No.2, Banjara Hills, Hyderabad 500033, Telangana. Dear Sirs, CERTIFIED For NATCO Pharma Limited M. ADINARAYANA Company
Page 3: natcopharma.co.in · M/S. NATCO Pharma Limited NATCO House, Road No.2, Banjara Hills, Hyderabad 500033, Telangana. Dear Sirs, CERTIFIED For NATCO Pharma Limited M. ADINARAYANA Company
Page 4: natcopharma.co.in · M/S. NATCO Pharma Limited NATCO House, Road No.2, Banjara Hills, Hyderabad 500033, Telangana. Dear Sirs, CERTIFIED For NATCO Pharma Limited M. ADINARAYANA Company
Page 5: natcopharma.co.in · M/S. NATCO Pharma Limited NATCO House, Road No.2, Banjara Hills, Hyderabad 500033, Telangana. Dear Sirs, CERTIFIED For NATCO Pharma Limited M. ADINARAYANA Company
Page 6: natcopharma.co.in · M/S. NATCO Pharma Limited NATCO House, Road No.2, Banjara Hills, Hyderabad 500033, Telangana. Dear Sirs, CERTIFIED For NATCO Pharma Limited M. ADINARAYANA Company

Natco Pharma Multibagger Report.… · 3 | P a g e Company Overview Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical

Natco Pharma Multibagger Report.… · 3 | P a g e Company Overview Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical

Documents
NATCO PHARMA LTD. V. BAYER CORPORATION AND THE COMPULSORY ...nujslawreview.org/wp-content/uploads/2016/12/mansi.pdf · NATCO PHARMA LTD. V. BAYER CORPORATION AND THE COMPULSORY LICENSING

NATCO PHARMA LTD. V. BAYER CORPORATION AND THE COMPULSORY ...nujslawreview.org/wp-content/uploads/2016/12/mansi.pdf · NATCO PHARMA LTD. V. BAYER CORPORATION AND THE COMPULSORY LICENSING

Documents
Volume No. I Issue No. 58 Natco Pharma Ltd. - FundsIndia · PDF fileFor private circulation only Company overview Natco Pharma Ltd. is a vertically integrated pharmaceutical company

Volume No. I Issue No. 58 Natco Pharma Ltd. - FundsIndia · PDF fileFor private circulation only Company overview Natco Pharma Ltd. is a vertically integrated pharmaceutical company

Documents
Natco Pharma Limited Q4 FY2020 Earnings Conference Call … · page 1 of 22 “natco pharma limited q4 fy2020 earnings conference call” june18, 2020 analyst: mr.prakash agarwal

Natco Pharma Limited Q4 FY2020 Earnings Conference Call … · page 1 of 22 “natco pharma limited q4 fy2020 earnings conference call” june18, 2020 analyst: mr.prakash agarwal

Documents
NATCO PHARMA LIMITED · Preliminary Placement Document Not for Circulation Private and Confidential Serial No. [ ] NATCO PHARMA LIMITED Originally incorporated as Natco Fine Pharmaceuticals

NATCO PHARMA LIMITED · Preliminary Placement Document Not for Circulation Private and Confidential Serial No. [ ] NATCO PHARMA LIMITED Originally incorporated as Natco Fine Pharmaceuticals

Documents
CORPORATE PRESENTATION - Natco · PDF fileDisclaimer / Important Disclosure This presentation has been prepared by Natco Pharma Limited (the “Company”) solely for information purposes

CORPORATE PRESENTATION - Natco · PDF fileDisclaimer / Important Disclosure This presentation has been prepared by Natco Pharma Limited (the “Company”) solely for information purposes

Documents
Th Laurels Galore! - Natco Pharma · 2015-03-24 · NATCO Pharma Limited 5 NOTICE Notice is hereby given that the Twenty Ninth Annual General Meeting of the Members of the Company

Th Laurels Galore! - Natco Pharma · 2015-03-24 · NATCO Pharma Limited 5 NOTICE Notice is hereby given that the Twenty Ninth Annual General Meeting of the Members of the Company

Documents
NATCO PHARMA LIMITED · Placement Document Not for Circulation Private and Confidential Serial No. [ ] NATCO PHARMA LIMITED Originally incorporated as Natco Fine Pharmaceuticals Private

NATCO PHARMA LIMITED · Placement Document Not for Circulation Private and Confidential Serial No. [ ] NATCO PHARMA LIMITED Originally incorporated as Natco Fine Pharmaceuticals Private

Documents
Natco Pharma AR 2010 · 2011. 3. 29. · NATCO Pharma Limited 5 NOTICE Notice is hereby given that the Twenty Seventh Annual General Meeting of the Members of the Company will be

Natco Pharma AR 2010 · 2011. 3. 29. · NATCO Pharma Limited 5 NOTICE Notice is hereby given that the Twenty Seventh Annual General Meeting of the Members of the Company will be

Documents
Natco Pharma (NATPHA) | 936static-news.moneycontrol.com/static-mcnews/2017/08/Natco_Pharma... · ICICI Securities Ltd | Page Retail Equity Research 3 Company Analysis Natco Pharma

Natco Pharma (NATPHA) | 936static-news.moneycontrol.com/static-mcnews/2017/08/Natco_Pharma... · ICICI Securities Ltd | Page Retail Equity Research 3 Company Analysis Natco Pharma

Documents
“Natco Pharma Limited Q2 FY2019 Earnings Conference Call” · Page 2 of 23 Moderator: Ladies and gentlemen good day and welcome to the Natco Pharma Q2 FY2019 Earnings Conference

“Natco Pharma Limited Q2 FY2019 Earnings Conference Call” · Page 2 of 23 Moderator: Ladies and gentlemen good day and welcome to the Natco Pharma Q2 FY2019 Earnings Conference

Documents
Gilead Sciences et. al. v. Natco Pharma et. al

Gilead Sciences et. al. v. Natco Pharma et. al

Documents
Natco Pharma (NATPHA) - ICICI Directcontent.icicidirect.com/mailimages/IDirect_NatcoPharma_Q3FY15.pdf · Q3 numbers were affected by loss of business in Venezuela overshadowing the

Natco Pharma (NATPHA) - ICICI Directcontent.icicidirect.com/mailimages/IDirect_NatcoPharma_Q3FY15.pdf · Q3 numbers were affected by loss of business in Venezuela overshadowing the

Documents
INDIA | PHARMA | COVERAGE INITIATIONjmflresearch.com › JMnew › JMCRM › analystreports › pdf › Natco_IC_… · Natco Pharma 11 June 2019 JM Financial Institutional Securities

INDIA | PHARMA | COVERAGE INITIATIONjmflresearch.com › JMnew › JMCRM › analystreports › pdf › Natco_IC_… · Natco Pharma 11 June 2019 JM Financial Institutional Securities

Documents
Natco Pharma Limited · NATCO PHARMA LIMITED Details regarding Voting results: As per Regulation 44 of SEBI {Listing Obligations and Disclosure Requirements) 2015 Resolution NO 2

Natco Pharma Limited · NATCO PHARMA LIMITED Details regarding Voting results: As per Regulation 44 of SEBI {Listing Obligations and Disclosure Requirements) 2015 Resolution NO 2

Documents
NATCO Pharma Limited Regd. Office: Natco House, Road No. 2, … · Segment reporting: (₹ in millions except share data) Year ended 30 June 2020 31 March 2020 30 June 2019 31 March

NATCO Pharma Limited Regd. Office: Natco House, Road No. 2, … · Segment reporting: (₹ in millions except share data) Year ended 30 June 2020 31 March 2020 30 June 2019 31 March

Documents
Natco Pharma Limitednatcopharma.co.in/wp-content/uploads/2016/02/Natco-Investor... · Important Disclosure 2 This presentation has been prepared by Natco Pharma Limited (the “Company”)solely

Natco Pharma Limitednatcopharma.co.in/wp-content/uploads/2016/02/Natco-Investor... · Important Disclosure 2 This presentation has been prepared by Natco Pharma Limited (the “Company”)solely

Documents
“Natco Pharma Limited Q4 FY2018 Earnings … · Page 1 of 24 “Natco Pharma Limited Q4 FY2018 Earnings Conference Call” May 24, 2018 ANALYST: MR. DEEPAK MALIK - EDELWEISS SECURITIES

“Natco Pharma Limited Q4 FY2018 Earnings … · Page 1 of 24 “Natco Pharma Limited Q4 FY2018 Earnings Conference Call” May 24, 2018 ANALYST: MR. DEEPAK MALIK - EDELWEISS SECURITIES

Documents
NATCO PHARMA LIMITED, Chemical Division RISK ASSESSMENT ...environmentclearance.nic.in/writereaddata/online/RiskAssessment/... · (i) NATCO PHARMA LIMITED, Chemical Division . RISK

NATCO PHARMA LIMITED, Chemical Division RISK ASSESSMENT ...environmentclearance.nic.in/writereaddata/online/RiskAssessment/... · (i) NATCO PHARMA LIMITED, Chemical Division . RISK

Documents
[June 2015] Strictly Private and Confidentialnatcopharma.co.in/wp-content/uploads/2015/03/Natco...3 Natco Pharma at a Glance Vertically integrated pharmaceutical company with focus

[June 2015] Strictly Private and Confidentialnatcopharma.co.in/wp-content/uploads/2015/03/Natco...3 Natco Pharma at a Glance Vertically integrated pharmaceutical company with focus

Documents
Research RETAIL EQUITY RESEARCH Natco pharma Ltd. …newsletter.geojit.com/researchnotes_new/research_note_2018-04-09... · gastroenterology) Source: Company, ... NATCO Pharma Canada

Research RETAIL EQUITY RESEARCH Natco pharma Ltd. …newsletter.geojit.com/researchnotes_new/research_note_2018-04-09... · gastroenterology) Source: Company, ... NATCO Pharma Canada

Documents
Natco pharma - pharma company analysis

Natco pharma - pharma company analysis

Business
Neural Networks Application in Predicting Stockprice of Pharma Companies a Case Study of Natco Pharma

Neural Networks Application in Predicting Stockprice of Pharma Companies a Case Study of Natco Pharma

Documents
NATCO TRUST A CSR INITIATIVE OF NATCO PHARMA …presence and the mentor’s home district. Corporate Approach Natco Trust witnessed a transition in the year 2008, when it changed hands

NATCO TRUST A CSR INITIATIVE OF NATCO PHARMA …presence and the mentor’s home district. Corporate Approach Natco Trust witnessed a transition in the year 2008, when it changed hands

Documents
NATCO PHARMA LIMITED INVESTOR PRESENTATION Q1 2020-21 · global generic pharma companies Focus on Para IV and First-to-File molecules Strengthening presence in Asia and other ROW

NATCO PHARMA LIMITED INVESTOR PRESENTATION Q1 2020-21 · global generic pharma companies Focus on Para IV and First-to-File molecules Strengthening presence in Asia and other ROW

Documents
Natco Pharmacontent.indiainfoline.com/.../Natco_091215.pdfNatco Pharma 2 Domestic oncology business will continue to grow at ~18% Natco is the key player in the domestic oncology segment

Natco Pharmacontent.indiainfoline.com/.../Natco_091215.pdfNatco Pharma 2 Domestic oncology business will continue to grow at ~18% Natco is the key player in the domestic oncology segment

Documents
INVESTOR PRESENTATION - Natco Pharma

INVESTOR PRESENTATION - Natco Pharma

Documents
Changing Times. Changing Strategies ... - Natco Pharma · NATCO PHARMA LIMITED ANNUAL REPORT 2016-17 Changing Times. Changing Strategies. 2 I I 3 We are driven by the commitment to

Changing Times. Changing Strategies ... - Natco Pharma · NATCO PHARMA LIMITED ANNUAL REPORT 2016-17 Changing Times. Changing Strategies. 2 I I 3 We are driven by the commitment to

Documents
NATCO Pharma Limited Expanding Horizons / Important Disclosure 2 This presentation has been prepared by Natco Pharma Limited (the “Company”) solely for information purposes without

NATCO Pharma Limited Expanding Horizons / Important Disclosure 2 This presentation has been prepared by Natco Pharma Limited (the “Company”) solely for information purposes without

Documents
ORGANIZING COMMITTEE NATCO Pharma Ltd · NATCO Research, NATCO Pharma Ltd. To be able to implement new techniques in teaching at their respective colleges. To be able to upgrade practical

ORGANIZING COMMITTEE NATCO Pharma Ltd · NATCO Research, NATCO Pharma Ltd. To be able to implement new techniques in teaching at their respective colleges. To be able to upgrade practical

Documents